PALI
Palisade Bio, Inc. Common Stock
stock NASDAQ

Out on PALI today at 1.40. Hit my take profit. In on ADIL. Looking for a move up to $1.

update $PALI eyes on august and end2025-early2026 catalysts

PALI again

Yes, you can ask these questions in the lounge. Personally, I would go all in on $MBOT, $PALI and $PHIO

Here are my top picks that I have done a lot of research on.
Microbot Medical Inc. ($MBOT)
Microbot Medical Inc is a post clinical stage medical device company featuring their LIBERTY® Endovascular Robotic System. Their robotic system has already passed all clinical trials with 100% success rate and reduced radiation by 92% which is groundbreaking in the healthcare industry. Their product already has 9 global patents including 1 in China, where the endovascular demand is surging. Liberty's founding team consists of professionals in robotics and in medical devices. The next step is FDA approval to sell in the U.S. Once this happens, they will be able to start producing these machines and selling them to hospitals. The stock is already up 12% in pre market and the FDA decision hasn't been released to the public yet.
Palisade Bio Inc. ($PALI)
Palisade Bio Inc.'s main product is the PALI-2108 which is a new oral medication designed to treat swelling, irritation, and soreness in the intestins, while specifically targeting ulcerative colitis and fibrostenotic Crohn’s disease. Currently, $PALI is still in Phase 1b of their clinical trial, meaning they have completed Phase 1a with super positive results, showing strong safety and effectiveness. As of April 9, 2025 they commenced dosing for patients in the Phase 1b. While Phase 1b is underway, Palisade is actively preparing, for PALI-2108's Phase 2. This clinical trial is advancing at a very fast pace. The study completion for Phase 1b could happen anytime now. In other words, this means that we could see news very soon.
Phio Pharmaceuticals Inc. ($PHIO)
In early 2025, Phio Pharmaceuticals Corp rallied by over 500% driven by strong early results from its lead clinical candidate - the PH-762's Phase 1a clinical trial. Their second product, PH-894, is currently in the IND clearance phase, awaiting FDA approval to begin clinical trials. You might be asking: Why hasn't $PHIO submitted the FDA request for their second candidate - the PH-894? This is because they are putting all their ressources in the PH-762 Phase 1b clinical trial which is the most promising. This Phase 1b trial is expected to finish in September 2025, but we could see more positive safety updates before then. In fact, in May, Phio announced a Positive Safety Monitoring Committee recommendation to advance the INTASYL PH-762 skin cancer clinical trial to its fifth dose escalation cohort — a strong sign of progress. For now, $PHIO is hanging at a steady price, but if they continue to advance in their Phase 1b, they will for sure get more positive comments which could drive the price up to 4.00$ and if it breaks this barrier, we could see a rally to 4.30$.

You might of never heard of these beasts, but they are for sure worth taking a look at. Have a good day, big gains coming soon!

Out on PALI today at 1.40. Hit my take profit. In on ADIL. Looking for a move up to $1.

update $PALI eyes on august and end2025-early2026 catalysts

PALI again

Yes, you can ask these questions in the lounge. Personally, I would go all in on $MBOT, $PALI and $PHIO

Here are my top picks that I have done a lot of research on.
Microbot Medical Inc. ($MBOT)
Microbot Medical Inc is a post clinical stage medical device company featuring their LIBERTY® Endovascular Robotic System. Their robotic system has already passed all clinical trials with 100% success rate and reduced radiation by 92% which is groundbreaking in the healthcare industry. Their product already has 9 global patents including 1 in China, where the endovascular demand is surging. Liberty's founding team consists of professionals in robotics and in medical devices. The next step is FDA approval to sell in the U.S. Once this happens, they will be able to start producing these machines and selling them to hospitals. The stock is already up 12% in pre market and the FDA decision hasn't been released to the public yet.
Palisade Bio Inc. ($PALI)
Palisade Bio Inc.'s main product is the PALI-2108 which is a new oral medication designed to treat swelling, irritation, and soreness in the intestins, while specifically targeting ulcerative colitis and fibrostenotic Crohn’s disease. Currently, $PALI is still in Phase 1b of their clinical trial, meaning they have completed Phase 1a with super positive results, showing strong safety and effectiveness. As of April 9, 2025 they commenced dosing for patients in the Phase 1b. While Phase 1b is underway, Palisade is actively preparing, for PALI-2108's Phase 2. This clinical trial is advancing at a very fast pace. The study completion for Phase 1b could happen anytime now. In other words, this means that we could see news very soon.
Phio Pharmaceuticals Inc. ($PHIO)
In early 2025, Phio Pharmaceuticals Corp rallied by over 500% driven by strong early results from its lead clinical candidate - the PH-762's Phase 1a clinical trial. Their second product, PH-894, is currently in the IND clearance phase, awaiting FDA approval to begin clinical trials. You might be asking: Why hasn't $PHIO submitted the FDA request for their second candidate - the PH-894? This is because they are putting all their ressources in the PH-762 Phase 1b clinical trial which is the most promising. This Phase 1b trial is expected to finish in September 2025, but we could see more positive safety updates before then. In fact, in May, Phio announced a Positive Safety Monitoring Committee recommendation to advance the INTASYL PH-762 skin cancer clinical trial to its fifth dose escalation cohort — a strong sign of progress. For now, $PHIO is hanging at a steady price, but if they continue to advance in their Phase 1b, they will for sure get more positive comments which could drive the price up to 4.00$ and if it breaks this barrier, we could see a rally to 4.30$.

You might of never heard of these beasts, but they are for sure worth taking a look at. Have a good day, big gains coming soon!

Go PALI!!

$PALI, $PHIO and $MBOT if they get FDA approval 

$MBOT and $PALI

Thank you!
Any further investors in PALI? Sounds interesting\~!